These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11260537)

  • 21. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
    Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excimer laser in the treatment of mycosis fungoides.
    Deaver D; Cauthen A; Cohen G; Sokol L; Glass F
    J Am Acad Dermatol; 2014 Jun; 70(6):1058-60. PubMed ID: 24775402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides.
    Lokitz ML; Wong HK
    Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):255-7. PubMed ID: 17986063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UVB in the management of early stage mycosis fungoides.
    Pavlotsky F; Barzilai A; Kasem R; Shpiro D; Trau H
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):565-72. PubMed ID: 16684285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open trial of climatotherapy at the Dead Sea for patch-stage mycosis fungoides.
    Hodak E; Gottlieb AB; Segal T; Maron L; Lotem M; Feinmesser M; David M
    J Am Acad Dermatol; 2004 Jul; 51(1):33-8. PubMed ID: 15243521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
    Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
    Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients.
    Piccinno R; Caccialanza M; Percivalle S
    J Dermatolog Treat; 2009; 20(3):165-8. PubMed ID: 18979277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses.
    Gettler SL; Fung MA
    Dermatol Online J; 2005 Dec; 11(3):6. PubMed ID: 16409902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
    Goldman BD; Oh SK; Davis BE; Kadin ME; Poiesz BJ; Koh HK
    Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of radiation therapy in mycosis fungoides refractory to systemic therapy.
    de Sanctis V; Persechino S; Fanelli A; Valeriani M; Bracci S; D'Arienzo M; Monarca B; Caperchi C; Raffa S; Enrici RM
    Eur J Dermatol; 2011; 21(2):213-7. PubMed ID: 21489904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
    Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
    J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
    Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
    Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
    Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting low-dose total skin electron beam therapy in mycosis fungoides.
    Harrison C; Young J; Navi D; Riaz N; Lingala B; Kim Y; Hoppe R
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e651-7. PubMed ID: 21489711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K; Rogers S; McNicholas PD; Collins P
    Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PUVA therapy and narrowband UVB therapy in Tunisian patients with mycosis fungoides.
    Khaled A; Fazaa B; Goucha S; Zeglaoui F; Kamoun MR
    Therapie; 2009; 64(6):389-94. PubMed ID: 20025842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and histological evaluation in patients with mycosis fungoides treated with UVA1.
    Trovato E; Pellegrino M; Filippi F; Mancini V; Pimpinelli N; Fimiani M
    G Ital Dermatol Venereol; 2020 Jun; 155(3):306-311. PubMed ID: 29368862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides.
    Hofer A; Cerroni L; Kerl H; Wolf P
    Arch Dermatol; 1999 Nov; 135(11):1377-80. PubMed ID: 10566837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.